The UNC CFAR is a consortium of three Institutions: UNC Chapel Hill, Research Triangle Institute (RTI), and Family Health International (FHl). All three institutions are part of the North Carolina Research Triangle Park, and RTI and FHl have historical links to UNC starting with their inception. The goal of the CFAR is promote the broad sweep of HIV/AIDS research through a variety of mechanisms. The CFAR provides core facilities specifically targeted to the needs of the HIV/AIDS research community. The CFAR Developmental Core supports new research initiatives from junior faculty, faculty new to HIV research, faculty at in-State HBCUs, and researchers at CFAR-linked international sites. The CFAR Developmental Awards program has been expanded by 50% with institutional funds, and this funding is further leveraged in partnership with departments and the CTSA in their developmental awards program. The CFAR sponsors the UNC CFAR HIV Clinical Cohort (UCHCC) database, which plays a central role In managing clinical HIV research activity at UNC, and the UCHCC Is part of the Inter-CFAR CNICS network, with the CNICS Biostatistics and Epidemiology Core now residing at UNC. A major strength of the UNC CFAR is our involvement in international work, with key links to Malawi, South Africa, China, Russia, Central America, and the DRC. These links facilitate international research, capacity building, and provide infrastructure for support of important NIH initiative such as the CHAVI and HPTN. Another important feature of our CFAR is our Clinical Pharmacology and Analytical Chemistry Core, which is unique among CFARs and has become a resource both for other CFARs and for several large NIH initiatives. The CFAR Cores and leadership are supporting four new initiatives: HIV latency and eradication;the IDU epidemic in St. Petersburg, Russia;AIDS malignancies;and HIV and the Criminal Justice System (in partnership with the NC State Department of Corrections). These areas are also supported by working groups, in addition to a long standing working group on Acute HIV Infection (in partnership with the NC State Health Department), and a new working group on Structural Determinants of HIV. The UNC CFAR also engages in a number of outreach programs, including developing a distance-learning program for our In-State HBCUs based on the UNC AIDS Course. In recognition of the importance of the CFAR, we receive significant institutional support including the assignment of space to the CFAR for CFAR investigators. The CFAR has become an essential part of the leadership, infrastructure, and identify of the HIV/AIDS research effort among our membership.

Public Health Relevance

The CFAR is committed to supporting research in treatment, prevention, epidemiology, and pathogenesis as part of an overall effort to change the course of the HIV epidemic both domestically and in the international setting. The CFAR provides infrastructure support for our membership, and leadership both within the membership and within the institutions.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI050410-15
Application #
8307282
Study Section
Special Emphasis Panel (ZAI1-ELB-A (J1))
Program Officer
Namkung, Ann S
Project Start
2001-08-20
Project End
2016-07-31
Budget Start
2012-08-01
Budget End
2013-07-31
Support Year
15
Fiscal Year
2012
Total Cost
$3,687,668
Indirect Cost
$1,115,073
Name
University of North Carolina Chapel Hill
Department
Biochemistry
Type
Schools of Medicine
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Masa, Rainier; Chowa, Gina; Nyirenda, Victor (2018) Chuma na Uchizi: A Livelihood Intervention to Increase Food Security of People Living with HIV in Rural Zambia. J Health Care Poor Underserved 29:349-372
Ong, Jason J; Fu, Hongyun; Pan, Stephen et al. (2018) Missed Opportunities for Human Immunodeficiency Virus and Syphilis Testing Among Men Who Have Sex With Men in China: A Cross-Sectional Study. Sex Transm Dis 45:382-386
Curtis 2nd, Alan D; Jensen, Kara; Van Rompay, Koen K A et al. (2018) A simultaneous oral and intramuscular prime/sublingual boost with a DNA/Modified Vaccinia Ankara viral vector-based vaccine induces simian immunodeficiency virus-specific systemic and mucosal immune responses in juvenile rhesus macaques. J Med Primatol 47:288-297
Yanik, Elizabeth L; Hernández-Ramírez, Raúl U; Qin, Li et al. (2018) Brief Report: Cutaneous Melanoma Risk Among People With HIV in the United States and Canada. J Acquir Immune Defic Syndr 78:499-504
Billock, Rachael M; Samoff, Erika; Cope, Anna B et al. (2018) Repeat Human Immunodeficiency Virus Testing by Transmission Risk Group and Rurality of Residence in North Carolina. Sex Transm Dis 45:684-689
Gausi, Blessings; Chagomerana, Maganizo B; Tang, Jennifer H et al. (2018) HIV Sero-discordance and dual contraceptive method use among HIV-infected men and women in Lilongwe, Malawi. Sex Transm Dis :
Zhou, Shuntai; Williford, Sara E; McGivern, David R et al. (2018) Evolutionary pathways to NS5A inhibitor resistance in genotype 1 hepatitis C virus. Antiviral Res 158:45-51
Grodensky, Catherine A; Golin, Carol E; Pack, Allison P et al. (2018) Adaptation and delivery of a motivational interviewing-based counseling program for persons acutely infected with HIV in Malawi: Implementation and lessons learned. Patient Educ Couns 101:1103-1109
Radtke, Kendra K; Bacchetti, Peter; Anastos, Kathryn et al. (2018) Use of Nonantiretroviral Medications That May Impact Neurocognition: Patterns and Predictors in a Large, Long-Term HIV Cohort Study. J Acquir Immune Defic Syndr 78:202-208
Watson, Julia; Tang, Weiming; Pan, Stephen et al. (2018) Out of the Closet, Into the Clinic: Opportunities for Expanding Men Who Have Sex With Men-Competent Services in China. Sex Transm Dis 45:527-533

Showing the most recent 10 out of 1688 publications